Bifidobacterium lactis HN019
“HN019® supports gut barrier function and bowel regularity.”
Backed by 100+ published studies, including 39+ human clinical studies.
Engineer
Supports gut barrier function, helps protect against harmful microbes, promotes regular bowel movements, and supports immune function.
Clinically evaluated for probiotic properties and human safety.
Health Benefits ofBifidobacterium lactis HN019
Digestive Health
- Survives stomach acid and bile to help maintain a balanced gut microbiome.¹
- Supports bowel regularity by helping reduce intestinal transit time and relieve constipation.²⁻⁴
- Promotes the growth of beneficial gut microbes, including Lactobacilli, Bifidobacteria, and Enterococci.⁵
- Supports digestive health in children.⁶
Immune Health
- Supports immune function and helps strengthen the body's natural defenses.⁷⁻⁹
Metabolic Health
- Supports cardiovascular health in individuals with metabolic syndrome.¹⁰
- Supports fat and glucose metabolism in individuals at high risk of metabolic syndrome.¹¹
- Hemalatha R et al. Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2-5-year-old children. Microb Ecol Health Dis. 2017 Mar 10;28(1):1298340. https://pubmed.ncbi.nlm.nih.gov/28572751/
- Waller P A et al. Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults. Scand J Gastroenterol. 2011 Sep;46(9):1057-64. https://pubmed.ncbi.nlm.nih.gov/21663486/
- Magro DO et al. Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation. Nutr J. 2014 Jul 24:13:75. https://pubmed.ncbi.nlm.nih.gov/25056655/
- Ibarra A et al. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial. Gut Microbes. 2018;9(3):236-251. https://pubmed.ncbi.nlm.nih.gov/29227175/
- Ahmed M et al. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects. J Nutr Health Aging. 2007 Jan-Feb;11(1):26-31. https://pubmed.ncbi.nlm.nih.gov/17315077/
- Hemalatha et al. A Community-based randomized double blind controlled trial of Lactobacillus paracasei and Bifidobacterium lactis on reducing risk for diarrhea and fever in preschool children in an urban slum in India. Eur J Nutr Food Saf. 2014. 4(4): 325-341. https://journalejnfs.com/index.php/EJNFS/article/view/144
- Gill H S et al. Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol. 2001 Jul;21(4):264-71. https://pubmed.ncbi.nlm.nih.gov/11506196/
- Miller L E et al. Effects of probiotic-containing products on stool frequency and intestinal transit in constipated adults: systematic review and meta- analysis of randomized controlled trials. Ann Gastroenterol. 2017. 30(6): 629-639. https://pubmed.ncbi.nlm.nih.gov/29118557/
- Miller L E et al. Contemporary meta-analysis of short- term probiotic consumption on gastrointestinal transit. World J Gastroenterol. 2016. 22(21): 5122-5131. https://pubmed.ncbi.nlm.nih.gov/27275105/
- Bernini LJ, et al. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome. Nutrition. 2016. 32(6): 716-719. https://pubmed.ncbi.nlm.nih.gov/27275105/
- Yu P et el. Effect of an oral probiotic formula on scalp and facial skin condition, glucose, and lipid metabolism. Funct FoodsHealth Dis.2022. 12(7): 394-409. https://www.ffhdj.com/index.php/ffhd/article/view/944
